Virelox Medical Devices Co., Ltd. is a leading professional orthopedic medical device manufacturer specializing in cutting-edge joint replacement systems and implantable surgical solutions. Operating under the globally recognized brand "Virelox", we dedicate our manufacturing intelligence and clinical engineering resources to delivering ultra-high performance orthopedic systems. Our product architecture addresses complex human trauma fixations, spinal reconstruction systems, joint revision interventions, and specialized veterinary surgical kits.
By coordinating a network of 850 certified upstream raw material and component partners, Virelox guarantees structural integrity and uninterrupted supplies. We serve medical device distributors, hospitals, trauma centers, and international healthcare procurement agencies across Europe, Southeast Asia, the Middle East, and South America.
Our ISO 13485-compliant quality control system leaves no margin for error. We deploy 65 specialized QA/QC professionals who manage a robust triple-verification framework (IQC, IPQC, FQC) utilizing state-of-the-art diagnostic platforms:
The global orthopedic surgery instruments and implants market is undergoing a structural transition. Driving forces include an aging worldwide demographic, a rising incidence of sports-related trauma injuries, and an increasing clinical preference for Minimally Invasive Spine Surgery (MISS). Hospitals and surgical centers require implants that offer faster osteointegration, lower infection risks, and longer structural lifespans. As a result, the demand for custom-fabricated, patient-specific orthopedic instrumentation has surged.
However, clinical procurement agents face distinct challenges: balancing cost restrictions against regulatory requirements (such as the transition from MDD to EU MDR 2017/745), ensuring biological and chemical cleanliness of titanium plates, and avoiding supply line disruptions. In this volatile market, sourcing medical devices from certified OEM/ODM factories is essential. These facilities must offer both cost efficiencies and clinical safety, backed by robust verification pathways.
An inside look at our 12,000 m² clean workshop facility, showcasing precision manufacturing from raw titanium blocks to certified sterile packaging.
Our portfolio of orthopedic implants and surgical instruments supports critical surgical procedures worldwide:
Virelox's engineering initiatives focus on several key areas:
Manufacturing implants in China, particularly through Virelox, offers major supply chain and engineering advantages:
Our advanced manufacturing ecosystem features complete vertical integration. By handling raw material sourcing, precision multi-axis CNC machining, ultrasonic cleaning, and cleanroom sterile packaging in-house, we prevent outsourcing delays and ensure strict quality control. Working with medical-grade titanium and cobalt-chromium suppliers allows us to source raw materials efficiently. This vertical integration makes Virelox a reliable partner for global medical device distributors, keeping lead times steady and pricing competitive without compromising quality.
Registering medical devices in different countries requires deep technical knowledge and thorough documentation. Virelox provides specialized regulatory support to help clients navigate compliance requirements in various markets:
Every batch of raw titanium (ASTM F136 / ISO 5832-3) undergoes strict chemical composition analysis. We assign a unique laser-etched laser code to every plate, screw, and tool we produce. This code links to our complete quality assurance history—from raw material logs to chemical cleaning and final sterilization—ensuring full traceability and accountability.